Nasdaq · Healthcare
DBV Technologies S.A. (DBVT)
As-reported financials and recent SEC filings for DBV Technologies S.A., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.6M
Net income
$-146.9M
Net margin
—
Diluted EPS
$-1.05
ROE
-87.1%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.6M | $4.2M | $15.7M | $4.8M | $5.7M |
| Gross profit | — | — | — | — | — |
| Operating income | $-147.1M | $-116.6M | $-76.4M | $-96.6M | $-98.6M |
| Net income | $-146.9M | $-113.9M | $72.7M | $96.3M | $-97.8M |
| Diluted EPS | $-1.05 | $-1.17 | $-0.76 | $-1.24 | $-1.78 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-29
View on EDGAR →8-K2026-06-05
View on EDGAR →S-82026-06-04
View on EDGAR →8-K2026-06-03
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →SCHEDULE 13G/A2026-05-13
View on EDGAR →SCHEDULE 13G/A2026-05-13
View on EDGAR →SCHEDULE 13G/A2026-05-12
View on EDGAR →Largest Healthcare peers
Go deeper on DBVT
Search DBV Technologies S.A.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.